Jiangsu Hengrui Medicine Co Ltd (600276) — Financial Flexibility Index
Jiangsu Hengrui Medicine Co Ltd (600276) has a Financial Flexibility Index of 0.63x as of September 2025. Free cash flow of CN¥5.26 Billion (operating CF CN¥4.81 Billion minus capex CN¥446.90 Million) represents 1% of total liabilities (CN¥8.30 Billion). Check how strategically is Jiangsu Hengrui Medicine Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jiangsu Hengrui Medicine Co Ltd Financial Flexibility Index (1999–2024)
Historical Financial Flexibility Index trend for Jiangsu Hengrui Medicine Co Ltd across 26 annual periods. See Jiangsu Hengrui Medicine Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Jiangsu Hengrui Medicine Co Ltd (1999–2024)
Year-by-year free cash flow to debt coverage for Jiangsu Hengrui Medicine Co Ltd. For the full company profile including market capitalisation, see Jiangsu Hengrui Medicine Co Ltd (600276) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.32x | CN¥9.39 Billion | CN¥7.42 Billion | CN¥4.05 Billion | ▼ -30.0% |
| 2023 | 3.32x | CN¥9.13 Billion | CN¥7.64 Billion | CN¥2.75 Billion | ▲ +301.4% |
| 2022 | 0.83x | CN¥3.26 Billion | CN¥1.27 Billion | CN¥3.94 Billion | ▼ -48.1% |
| 2021 | 1.59x | CN¥5.88 Billion | CN¥4.22 Billion | CN¥3.69 Billion | ▲ +57.5% |
| 2020 | 1.01x | CN¥3.99 Billion | CN¥3.43 Billion | CN¥3.94 Billion | ▼ -39.5% |
| 2019 | 1.67x | CN¥4.38 Billion | CN¥3.82 Billion | CN¥2.62 Billion | ▲ +29.7% |
| 2018 | 1.29x | CN¥3.30 Billion | CN¥2.77 Billion | CN¥2.56 Billion | ▼ -7.7% |
| 2017 | 1.40x | CN¥2.93 Billion | CN¥2.55 Billion | CN¥2.10 Billion | ▼ -45.1% |
| 2016 | 2.54x | CN¥3.70 Billion | CN¥2.59 Billion | CN¥1.46 Billion | ▲ +8.5% |
| 2015 | 2.35x | CN¥2.67 Billion | CN¥2.28 Billion | CN¥1.14 Billion | ▼ -0.2% |
| 2014 | 2.35x | CN¥1.87 Billion | CN¥1.57 Billion | CN¥796.98 Million | ▼ -27.1% |
| 2013 | 3.22x | CN¥1.82 Billion | CN¥1.36 Billion | CN¥564.40 Million | ▲ +1.7% |
| 2012 | 3.17x | CN¥1.43 Billion | CN¥958.37 Million | CN¥450.01 Million | ▲ +30.4% |
| 2011 | 2.43x | CN¥1.07 Billion | CN¥527.36 Million | CN¥439.47 Million | ▲ +52.0% |
| 2010 | 1.60x | CN¥672.68 Million | CN¥385.95 Million | CN¥420.80 Million | ▼ -8.1% |
| 2009 | 1.74x | CN¥580.77 Million | CN¥439.12 Million | CN¥333.85 Million | ▲ +74.9% |
| 2008 | 0.99x | CN¥228.67 Million | CN¥117.46 Million | CN¥229.91 Million | ▲ +32.5% |
| 2007 | 0.75x | CN¥285.72 Million | CN¥218.87 Million | CN¥380.51 Million | ▼ -57.2% |
| 2006 | 1.75x | CN¥352.47 Million | CN¥266.18 Million | CN¥201.07 Million | ▲ +6.7% |
| 2005 | 1.64x | CN¥290.94 Million | CN¥227.88 Million | CN¥177.10 Million | ▲ +46.5% |
| 2004 | 1.12x | CN¥288.52 Million | CN¥209.41 Million | CN¥257.33 Million | ▲ +73.6% |
| 2003 | 0.65x | CN¥353.44 Million | CN¥136.82 Million | CN¥547.34 Million | ▲ +47.5% |
| 2002 | 0.44x | CN¥172.74 Million | CN¥49.84 Million | CN¥394.60 Million | ▼ -44.9% |
| 2001 | 0.80x | CN¥287.07 Million | CN¥11.49 Million | CN¥361.03 Million | ▲ +147.1% |
| 2000 | 0.32x | CN¥100.95 Million | CN¥19.61 Million | CN¥313.71 Million | ▲ +78.8% |
| 1999 | 0.18x | CN¥54.21 Million | CN¥33.89 Million | CN¥301.17 Million | — |